Something rotten in the state of clinical and economic evaluations?

[1]  D G Altman,et al.  The scandal of poor medical research , 1994, BMJ.

[2]  P. Rochon,et al.  A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. , 1994, Archives of internal medicine.

[3]  R Smith.  Conflict of interest and the BMJ , 1994, BMJ.

[4]  F. Song,et al.  Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. , 1993, BMJ.

[5]  T. Sheldon,et al.  Consensus conferences as drug promotion , 1993, The Lancet.

[6]  T C Chalmers,et al.  Getting to grips with Archie Cochrane's agenda. , 1992, BMJ.

[7]  J. G. Edwards.  Selective serotonin reuptake inhibitors. , 1992, BMJ.

[8]  Thomas C. Chalmers,et al.  Economic Analysis in Randomized Control Trials , 1992, Medical care.

[9]  G A Colditz,et al.  Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature , 1992, Annals of Internal Medicine.

[10]  G. Dunbar,et al.  A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients , 1991, British Journal of Psychiatry.

[11]  B Kinosian,et al.  Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. , 1991, The New England journal of medicine.

[12]  P. Easterbrook,et al.  Publication bias in clinical research , 1991, The Lancet.

[13]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[14]  R N Battista,et al.  Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination. , 1990, Journal of clinical epidemiology.

[15]  P. Gøtzsche.  Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. , 1989, Controlled clinical trials.

[16]  A. Feinstein.  Fraud, distortion, delusion, and consensus: the problems of human and natural deception in epidemiologic science. , 1988, The American journal of medicine.

[17]  C. Mulrow.  The medical review article: state of the science. , 1987, Annals of internal medicine.

[18]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[19]  D. Sackett,et al.  The Ends of Human Life: Medical Ethics in a Liberal Polity , 1992, Annals of Internal Medicine.

[20]  S. Pocock,et al.  Clinical Trials: A Practical Approach , 1984 .

[21]  J. Bailar,et al.  Bailar's laws of data analysis , 1976 .

[22]  A. Williams,et al.  The cost-benefit approach. , 1974, British medical bulletin.

[23]  R. Ekins.  BASIC PRINCIPLES AND THEORY , 1974 .